Abstract
Concept and feasibility of the Augsburg longitudinal plasma study (ALPS) – A prospective trial for comprehensive liquid biopsy-based longitudinal monitoring of solid cancer patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have